Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMT in Healthy Subjects
NCT04353024Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Jun 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DMT (5 arms), sponsored by University Hospital Basel. Primary endpoints: Altered states of consciousness profile at 150 minutes and Subjective effect ratings over time at 150 minutes. Started Jun 2021; status: completed.
02
Drugs
DMT
Beyond the preview
Go deeper on NCT04353024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04353024.